Off-Label Communications: Legislative Reform Efforts Struggle, But Continue
Executive Summary
At hearing, House Energy & Commerce Committee leadership supports legislation to provide clarity and more latitude in off-label communications at hearing but Democrats oppose broad change.
You may also be interested in...
Unapproved Uses Bill May Eventually Pass, But Would Likely Need Additional Safeguards
Off-label communication amendments tabled at House markup of user fee legislation after Democrats object; the two sides agreed to discuss the issue further down the road.
Industry Communications With Payors: US FDA Okays Info On Investigational Drugs
Draft guidance provides clarity on what health care economic information firms can provide to payors, formulary committees and similar entities.
'Safe Harbor' For Preapproval Information Exchange To Get Legislative Push
US Academy of Managed Care Pharmacy is developing language to protect exchange of clinical and economic information on pipeline products between manufacturers and healthcare decision-makers; safe harbor could find a home in legislation reauthorizing FDA user fee programs.